Back to SYRE

Fairmount Funds Management LLC → SYRE

Fairmount Funds Management LLC SYRE Position History

Spyre Therapeutics, Inc. • Healthcare

Quarters held
2
Latest value
$202.7M
Q1 2026
Peak value
$202.7M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$131.6M
Q1 2026$202.7M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q1 2026$202.7M4.02M——
Q4 2025$131.6M4.02M——

Other funds holding SYRE

Other Fairmount Funds Management LLC positions

ORKA

ORUKA THERAPEUTICS INC

$352.6M
COGT

COGENT BIOSCIENCES INC

$319.8M
ORKA

ORUKA THERAPEUTICS INC

$308.6M
KRSA

KORSANA BIOSCIENCES INC

$291.3M
DNTH

DIANTHUS THERAPEUTICS INC

$247.3M
DNTH

DIANTHUS THERAPEUTICS INC

$223.4M
COGT

COGENT BIOSCIENCES INC

$213M
DNTH

DIANTHUS THERAPEUTICS INC

$212.9M